The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence–derived tumor volume from baseline MRI and postprostatectomy outcomes following neoadjuvant hormonal therapy for patients with high-risk prostate cancer.
 
David Yang
No Relationships to Disclose
 
Leslie Lee
No Relationships to Disclose
 
Praful Ravi
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); Novartis (Inst); Telix Pharmaceuticals (Inst)
 
Saahil Rastogi
No Relationships to Disclose
 
Fiona Fennessy
No Relationships to Disclose
 
Adam Kibel
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Janssen; Pfizer; Profound
 
Quoc-Dien Trinh
Honoraria - Astellas Oncology; Bayer; Intuitive Surgical; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Bayer
Research Funding - Pfizer
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Anthony DAmico
No Relationships to Disclose
 
Paul Nguyen
Stock and Other Ownership Interests - Nanocan Therapeutics; Reversal Therapeutics; Stratagen Bio; Telerad Oncology; Volatilyx (I)
Consulting or Advisory Role - AIQ Solutions; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Myovant Sciences; Nanocan Therapeutics; Novartis; Theranano
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
 
Eliezer Van Allen
Stock and Other Ownership Interests - ervaxx; Genome Medical; Genomic Life; Manifold Bio; Microsoft; Monte Rosa Therapeutics; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Consulting or Advisory Role - ervaxx; Genome Medical; Genomic Life; Illumina; Janssen; Manifold Bio; Monte Rosa Therapeutics; Novartis; Riva Therapeutics; Serinus Bio; Syapse; Tango Therapeutics
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis; Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent on clinical interpretation algorithms using cancer molecular data (Inst); Patent on discovery of chromatin regulators as biomarkers of response to cancer immunotherapy (Inst); Patent on discovery of retained intron as source of cancer neoantigens (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Mary-Ellen Taplin
Honoraria - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Clovis Oncology; Flare Therapeutics; Interpublic GIS; Janssen-Ortho; MJH Healthcare Holdings, LLC; Pfizer; Physicans' Education Resource; Propella Therapeutics; Research to Practice; UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Flare Therapeutics; Geode Therapeutics; Janssen-Ortho; Novartis; Pfizer; Propella Therapeutics; UpToDate
Research Funding - Janssen-Ortho (Inst)
Travel, Accommodations, Expenses - Advanced Prostate Cancer Society; Prostate Cancer Foundation; South West Prostate Cancer Symposium
 
Martin King
Research Funding - Bayer; Palette Life Sciences